BRAF V600E

Clinical trials for BRAF V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E trials appear

Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Targeted attack on mutant lung cancer shows promise

Disease control Ongoing

This study is testing whether a combination of two targeted drugs, encorafenib and binimetinib, can help control advanced non-small cell lung cancer that has a specific genetic change called BRAF V600E. It is for adults whose cancer has spread and who have either had no prior tre…

Matched conditions: BRAF V600E

Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

BRAF V600E

Get alerted when new BRAF V600E trials appear

Targeted attack on mutant lung cancer shows promise